Focal Point on Biotechnology in Osaka

Boasting a high concentration of medical research facilities and pharma companies, Osaka is ideally situated to incubate and develop emerging biomedical technologies.

The city of Osaka in Japan is making great strides towards becoming an international hub in biomedical innovation.

Framing the process of ageing more as a treatable condition, rather than an inevitable consequence of life, could allow people to live longer, thanks to emerging biotechnologies and a greater emphasis on healthy living.

With its new facility in Osaka, CSL aims to accelerate its drug-development efforts through extensive collaboration with Japan’s biomedical research community.

Ultrafine bubbles induce new properties that can change how we can use water.

A promising new technology makes it easier to diagnose dementia earlier, when a diagnosis can really make a difference.

A greater emphasis on promoting disease prevention by life-insurance companies aims to benefit policyholders.

Using induced pluripotent stem cells for drug repurposing and testing pre-symptomatic diseases, are two ways a Japanese pharmaceutical company is innovating.